Apollo Hospitals Enterprise Limited vs Dr. Lal Path Labs Ltd.

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Dr. Lal Path Labs Ltd. (LALPATHLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs LALPATHLAB on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability13
  • Growth20
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
62.64
13.46
P/B ratio
12.83
0.22%
Dividend yield
0.26%
₹135.04
EPS
₹30.24

Profitability

LALPATHLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
20.13%
17.31%
Return on capital
25.56%
14.94%
EBITDA margin
28.32%
7.94%
Net margin
18.45%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
11.06%
33.35%
Profit CAGR (3Y)
28.35%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹31,206 Cr
₹25,229 Cr
Revenue
₹2,763 Cr
₹2,003 Cr
Net profit
₹510 Cr
0.90
Debt / equity
0.08
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
Dr. Lal Path Labs Ltd.
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 22.3%", "Company has been maintaining a healthy dividend payout of 67.5%", "Company is almost debt free."]
  • − ["Stock is trading at 12.45 times its book value"]
Apollo Hospitals Enterprise Limited full analysis Dr. Lal Path Labs Ltd. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs LALPATHLAB: Share Price, Valuation & Which to Buy | DocStoX